Exchange: NASDAQ·Updated 04:10 PM EDT
News
all
press releases
Ardelyx (ARDX) Securities Investigation Notice - Levi & Korsinsky
Ardelyx (ARDX) Securities Investigation Notice - Levi & Korsinsky Ardelyx (ARDX) Securities Investigation Notice - Levi & Korsinsky PR Newswire NEW YORK, Aug. 20, 2026 Ardelyx guided investors to $410-$430 million in 2026 IBSRELA revenue and reiterated that range on April 30, 2026. On August 6, the...
PR Newswire
More News
ARDX Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Ardelyx (ARDX)
Every 100 shares of Ardelyx (NASDAQ: ARDX) held into August 7, 2026 lost about $87 in value as the stock fell 17.86% to close at $4.00 following the Company's second quarter report. If you held ARDX shares and lost money, you are encouraged to submit your loss information for review. You may also...
Business Wire
ARDX SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Ardelyx
ARDX SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Ardelyx ARDX SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Ardelyx PR Newswire NEW YORK, Aug. 14, 2026 Ardelyx cut its 2026 IBSRELA revenue...
PR Newswire
Ardelyx Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Ardelyx (ARDX)
Ardelyx Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Ardelyx (ARDX) Ardelyx Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Ardelyx (ARDX) PR Newswire NEW YORK, Aug. 13, 2026 ARDX closed at $4.00 on August 7, 2026...
PR Newswire
Ardelyx (ARDX) Q2 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
New Strong Sell Stocks for August 7th
ARDX, ARDT and GPRE have been added to the Zacks Rank #5 (Strong Sell) List on August 7th, 2026.
Zacks
Ardelyx (ARDX) Reports Q2 Loss, Lags Revenue Estimates
Ardelyx (ARDX) delivered earnings and revenue surprises of -40.00% and -2.27%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Compared to Estimates, Ardelyx (ARDX) Q2 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Ardelyx (ARDX) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks
Indivior Pharmaceuticals Inc. (INDV) Q2 Earnings and Revenues Beat Estimates
Indivior Pharmaceuticals Inc. (INDV) delivered earnings and revenue surprises of +18.56% and +11.36%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Will Ardelyx (ARDX) Report Negative Earnings Next Week? What You Should Know
Ardelyx (ARDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks

Advertisement|Remove ads.